Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Population-Based Surveillance for Birth Defects Potentially Related to Zika Virus Infection - 22 States and Territories, January 2016-June 2017.

Smoots AN, Olson SM, Cragan J, Delaney A, Roth NM, Godfred-Cato S, Jones AM, Nahabedian JF 3rd, Fornoff J, Sandidge T, Yazdy MM, Higgins C, Olney RS, Eckert V, Forkner A, Fox DJ, Stolz A, Crawford K, Cho SJ, Knapp M, Ahmed MF, Lake-Burger H, Elmore AL, Langlois P, Breidenbach R, Nance A, Denson L, Caton L, Forestieri N, Bergman K, Humphries BK, Leedom VO, Tran T, Johnston J, Valencia-Prado M, Pérez-González S, Romitti PA, Fall C, Bryan JM, Barton J, Arias W, St John K, Mann S, Kimura J, Orantes L, Martin B, de Wilde L, Ellis EM, Song Z, Akosa A, Goodroe C, Ellington SR, Tong VT, Gilboa SM, Moore CA, Honein MA.

MMWR Morb Mortal Wkly Rep. 2020 Jan 24;69(3):67-71. doi: 10.15585/mmwr.mm6903a3.

2.

Zika Virus Detection in Amniotic Fluid and Zika-Associated Birth Defects.

Reyes MM, Ailes EC, Daza M, Tong VT, Osorio J, Valencia D, Turca AR, Galang RR, González Duarte M, Ricaldi JN, Anderson KN, Kamal N, Thomas JD, Villanueva J, Burkel VK, Meaney-Delman D, Gilboa SM, Honein MA, Jamieson DJ, Martinez MO.

Am J Obstet Gynecol. 2020 Jan 15. pii: S0002-9378(20)30013-2. doi: 10.1016/j.ajog.2020.01.009. [Epub ahead of print]

PMID:
31954155
3.

Better surveillance to protect mothers and infants from Zika.

Gilboa SM, Gregory CJ, Honein MA.

Lancet Infect Dis. 2019 Oct;19(10):1047-1048. doi: 10.1016/S1473-3099(19)30473-6. No abstract available.

PMID:
31559951
4.

Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011.

Tinker SC, Gilboa SM, Moore CA, Waller DK, Simeone RM, Kim SY, Jamieson DJ, Botto LD, Reefhuis J; National Birth Defects Prevention Study.

Am J Obstet Gynecol. 2020 Feb;222(2):176.e1-176.e11. doi: 10.1016/j.ajog.2019.08.028. Epub 2019 Aug 24.

PMID:
31454511
5.

Updated baseline prevalence of birth defects potentially related to Zika virus infection.

Olson SM, Delaney A, Jones AM, Carr CP, Liberman RF, Forestieri NE, Tong VT, Gilboa SM, Honein MA, Moore CA, Cragan JD.

Birth Defects Res. 2019 Aug 1;111(13):938-940. doi: 10.1002/bdr2.1546. Epub 2019 Jul 2. No abstract available.

PMID:
31264801
6.

Potential risk factors for Ebstein anomaly, National Birth Defects Prevention Study, 1997-2011.

Downing KF, Riehle-Colarusso T, Gilboa SM, Lin AE, Oster ME, Tinker SC, Farr SL; National Birth Defects Prevention Study.

Cardiol Young. 2019 Jun;29(6):819-827. doi: 10.1017/S1047951119000970. Epub 2019 Jun 4.

PMID:
31159903
7.

Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011.

Tinker SC, Reefhuis J, Bitsko RH, Gilboa SM, Mitchell AA, Tran EL, Werler MM, Broussard CS; National Birth Defects Prevention Study.

Birth Defects Res. 2019 Jun 1;111(10):613-620. doi: 10.1002/bdr2.1497. Epub 2019 Mar 19.

PMID:
30891943
8.

Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection - U.S. Territories and Freely Associated States, 2018.

Rice ME, Galang RR, Roth NM, Ellington SR, Moore CA, Valencia-Prado M, Ellis EM, Tufa AJ, Taulung LA, Alfred JM, Pérez-Padilla J, Delgado-López CA, Zaki SR, Reagan-Steiner S, Bhatnagar J, Nahabedian JF 3rd, Reynolds MR, Yeargin-Allsopp M, Viens LJ, Olson SM, Jones AM, Baez-Santiago MA, Oppong-Twene P, VanMaldeghem K, Simon EL, Moore JT, Polen KD, Hillman B, Ropeti R, Nieves-Ferrer L, Marcano-Huertas M, Masao CA, Anzures EJ, Hansen RL Jr, Pérez-Gonzalez SI, Espinet-Crespo CP, Luciano-Román M, Shapiro-Mendoza CK, Gilboa SM, Honein MA.

MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867. doi: 10.15585/mmwr.mm6731e1.

9.

Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Men with Possible Zika Virus Exposure - United States, August 2018.

Polen KD, Gilboa SM, Hills S, Oduyebo T, Kohl KS, Brooks JT, Adamski A, Simeone RM, Walker AT, Kissin DM, Petersen LR, Honein MA, Meaney-Delman D.

MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):868-871. doi: 10.15585/mmwr.mm6731e2.

10.

Estimating the numbers of pregnant women infected with Zika virus and infants with congenital microcephaly in Colombia, 2015-2017.

Adamski A, Bertolli J, Castañeda-Orjuela C, Devine OJ, Johansson MA, Duarte MAG, Farr SL, Tinker SC, Reyes MMM, Tong VT, Garcia OEP, Valencia D, Ortiz DAC, Honein MA, Jamieson DJ, Martínez MLO, Gilboa SM.

J Infect. 2018 Jun;76(6):529-535. doi: 10.1016/j.jinf.2018.02.010. Epub 2018 Apr 6.

PMID:
29627357
11.

Public Health Approach to Addressing the Needs of Children Affected by Congenital Zika Syndrome.

Broussard CS, Shapiro-Mendoza CK, Peacock G, Rasmussen SA, Mai CT, Petersen EE, Galang RR, Newsome K, Reynolds MR, Gilboa SM, Boyle CA, Moore CA.

Pediatrics. 2018 Feb;141(Suppl 2):S146-S153. doi: 10.1542/peds.2017-2038C. Review.

12.

Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections - United States, 2014.

Ailes EC, Summers AD, Tran EL, Gilboa SM, Arnold KE, Meaney-Delman D, Reefhuis J.

MMWR Morb Mortal Wkly Rep. 2018 Jan 12;67(1):18-22. doi: 10.15585/mmwr.mm6701a4.

13.

Birth defect survival for Hispanic subgroups.

Lopez KN, Nembhard WN, Wang Y, Liu G, Kucik JE, Copeland G, Gilboa SM, Kirby RS, Canfield M.

Birth Defects Res. 2018 Mar 1;110(4):352-363. doi: 10.1002/bdr2.1157. Epub 2017 Dec 1.

14.

Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011.

Interrante JD, Ailes EC, Lind JN, Anderka M, Feldkamp ML, Werler MM, Taylor LG, Trinidad J, Gilboa SM, Broussard CS; National Birth Defects Prevention Study.

Ann Epidemiol. 2017 Oct;27(10):645-653.e2. doi: 10.1016/j.annepidem.2017.09.003. Epub 2017 Sep 20.

15.

Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.

Lynch MM, Amoozegar JB, McClure EM, Squiers LB, Broussard CS, Lind JN, Polen KN, Frey MT, Gilboa SM, Biermann J.

Qual Health Res. 2017 Nov;27(13):2071-2080. doi: 10.1177/1049732317732027. Epub 2017 Oct 3.

16.

Making Decisions About Medication Use During Pregnancy: Implications for Communication Strategies.

Lynch MM, Squiers LB, Kosa KM, Dolina S, Read JG, Broussard CS, Frey MT, Polen KN, Lind JN, Gilboa SM, Biermann J.

Matern Child Health J. 2018 Jan;22(1):92-100. doi: 10.1007/s10995-017-2358-0.

17.

Zika Virus Disease in Children in Colombia, August 2015 to May 2016.

Tolosa N, Tinker SC, Pacheco O, Valencia D, Botero DS, Tong VT, Mercado M, Gilboa SM, Gonzalez M, Nelson CA, Pardo L, Rao CY, Rico A, Moore M, Parra E, Honein MA, Ospina Martínez ML.

Paediatr Perinat Epidemiol. 2017 Nov;31(6):537-545. doi: 10.1111/ppe.12391. Epub 2017 Aug 14.

PMID:
28806479
18.

Serial Head and Brain Imaging of 17 Fetuses With Confirmed Zika Virus Infection in Colombia, South America.

Parra-Saavedra M, Reefhuis J, Piraquive JP, Gilboa SM, Badell ML, Moore CA, Mercado M, Valencia D, Jamieson DJ, Beltran M, Sanz-Cortes M, Rivera-Casas AM, Yepez M, Parra G, Ospina Martinez M, Honein MA.

Obstet Gynecol. 2017 Jul;130(1):207-212. doi: 10.1097/AOG.0000000000002105.

19.

Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Lind JN, Interrante JD, Ailes EC, Gilboa SM, Khan S, Frey MT, Dawson AL, Honein MA, Dowling NF, Razzaghi H, Creanga AA, Broussard CS.

Pediatrics. 2017 Jun;139(6). pii: e20164131. doi: 10.1542/peds.2016-4131. Review.

20.

Maternal Exposure to Nitrogen Dioxide, Intake of Methyl Nutrients, and Congenital Heart Defects in Offspring.

Stingone JA, Luben TJ, Carmichael SL, Aylsworth AS, Botto LD, Correa A, Gilboa SM, Langlois PH, Nembhard WN, Richmond-Bryant J, Shaw GM, Olshan AF; National Birth Defects Prevention Study.

Am J Epidemiol. 2017 Sep 15;186(6):719-729. doi: 10.1093/aje/kwx139.

21.

Population-based pregnancy and birth defects surveillance in the era of Zika virus.

Gilboa SM, Mai CT, Shapiro-Mendoza CK, Cragan JD, Moore CA, Meaney-Delman DM, Jamieson DJ, Honein MA, Boyle CA.

Birth Defects Res. 2017 Mar 15;109(5):372-378. doi: 10.1002/bdr2.1007.

PMID:
28398681
22.

Factors associated with employment status before and during pregnancy: Implications for studies of pregnancy outcomes.

Rocheleau CM, Bertke SJ, Lawson CC, Romitti PA, Desrosiers TA, Agopian AJ, Bell E, Gilboa SM; National Birth Defects Prevention Study.

Am J Ind Med. 2017 Apr;60(4):329-341. doi: 10.1002/ajim.22700.

PMID:
28299820
23.

Baseline Prevalence of Birth Defects Associated with Congenital Zika Virus Infection - Massachusetts, North Carolina, and Atlanta, Georgia, 2013-2014.

Cragan JD, Mai CT, Petersen EE, Liberman RF, Forestieri NE, Stevens AC, Delaney A, Dawson AL, Ellington SR, Shapiro-Mendoza CK, Dunn JE, Higgins CA, Meyer RE, Williams T, Polen KN, Newsome K, Reynolds M, Isenburg J, Gilboa SM, Meaney-Delman DM, Moore CA, Boyle CA, Honein MA.

MMWR Morb Mortal Wkly Rep. 2017 Mar 3;66(8):219-222. doi: 10.15585/mmwr.mm6608a4.

24.

Preliminary Report of Microcephaly Potentially Associated with Zika Virus Infection During Pregnancy - Colombia, January-November 2016.

Cuevas EL, Tong VT, Rozo N, Valencia D, Pacheco O, Gilboa SM, Mercado M, Renquist CM, González M, Ailes EC, Duarte C, Godoshian V, Sancken CL, Turca AM, Calles DL, Ayala M, Morgan P, Perez EN, Bonilla HQ, Gomez RC, Estupiñan AC, Gunturiz ML, Meaney-Delman D, Jamieson DJ, Honein MA, Martínez ML.

MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1409-1413. doi: 10.15585/mmwr.mm6549e1.

25.

Proportion of selected congenital heart defects attributable to recognized risk factors.

Simeone RM, Tinker SC, Gilboa SM, Agopian AJ, Oster ME, Devine OJ, Honein MA; National Birth Defects Prevention Study.

Ann Epidemiol. 2016 Dec;26(12):838-845. doi: 10.1016/j.annepidem.2016.10.003. Epub 2016 Oct 26.

26.

Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.

Ailes EC, Gilboa SM, Gill SK, Broussard CS, Crider KS, Berry RJ, Carter TC, Hobbs CA, Interrante JD, Reefhuis J; and The National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):940-949. doi: 10.1002/bdra.23570.

27.

Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Ailes EC, Simeone RM, Dawson AL, Petersen EE, Gilboa SM.

Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):927-934. doi: 10.1002/bdra.23573.

28.

Maternal exposure to ozone and PM2.5 and the prevalence of orofacial clefts in four U.S. states.

Zhou Y, Gilboa SM, Herdt ML, Lupo PJ, Flanders WD, Liu Y, Shin M, Canfield MA, Kirby RS.

Environ Res. 2017 Feb;153:35-40. doi: 10.1016/j.envres.2016.11.007. Epub 2016 Nov 23.

29.

Estimating the Number of Pregnant Women Infected With Zika Virus and Expected Infants With Microcephaly Following the Zika Virus Outbreak in Puerto Rico, 2016.

Ellington SR, Devine O, Bertolli J, Martinez Quiñones A, Shapiro-Mendoza CK, Perez-Padilla J, Rivera-Garcia B, Simeone RM, Jamieson DJ, Valencia-Prado M, Gilboa SM, Honein MA, Johansson MA.

JAMA Pediatr. 2016 Oct 1;170(10):940-945. doi: 10.1001/jamapediatrics.2016.2974.

PMID:
27544075
30.

Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010.

Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, Xu P, Correa A, Jenkins K, Marelli AJ.

Circulation. 2016 Jul 12;134(2):101-9. doi: 10.1161/CIRCULATIONAHA.115.019307. Epub 2016 Jul 5.

31.

Reporting of birth defects in SART CORS: time to rely on data linkage.

Mendola P, Gilboa SM.

Fertil Steril. 2016 Sep 1;106(3):554-5. doi: 10.1016/j.fertnstert.2016.06.020. Epub 2016 Jun 22. No abstract available.

32.

Zika and the Risk of Microcephaly.

Johansson MA, Mier-y-Teran-Romero L, Reefhuis J, Gilboa SM, Hills SL.

N Engl J Med. 2016 Jul 7;375(1):1-4. doi: 10.1056/NEJMp1605367. Epub 2016 May 25. No abstract available. Erratum in: N Engl J Med. 2016 Aug 4;375(5):498.

33.

Projecting Month of Birth for At-Risk Infants after Zika Virus Disease Outbreaks.

Reefhuis J, Gilboa SM, Johansson MA, Valencia D, Simeone RM, Hills SL, Polen K, Jamieson DJ, Petersen LR, Honein MA.

Emerg Infect Dis. 2016 May;22(5):828-32. doi: 10.3201/eid2205.160290.

34.

Limitations, depressive symptoms, and quality of life among a population-based sample of young adults with congenital heart defects.

Farr SL, Oster ME, Simeone RM, Gilboa SM, Honein MA.

Birth Defects Res A Clin Mol Teratol. 2016 Jul;106(7):580-6. doi: 10.1002/bdra.23498. Epub 2016 Mar 17.

35.

Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013.

Dawson AL, Ailes EC, Gilboa SM, Simeone RM, Lind JN, Farr SL, Broussard CS, Reefhuis J, Carrino G, Biermann J, Honein MA.

MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):41-6. doi: 10.15585/mmwr.mm6503a1.

36.

Survival of children with trisomy 13 and trisomy 18: A multi-state population-based study.

Meyer RE, Liu G, Gilboa SM, Ethen MK, Aylsworth AS, Powell CM, Flood TJ, Mai CT, Wang Y, Canfield MA; National Birth Defects Prevention Network.

Am J Med Genet A. 2016 Apr;170A(4):825-37. doi: 10.1002/ajmg.a.37495. Epub 2015 Dec 10.

37.

Population-based birth defects data in the United States, 2008 to 2012: Presentation of state-specific data and descriptive brief on variability of prevalence.

Mai CT, Isenburg J, Langlois PH, Alverson CJ, Gilboa SM, Rickard R, Canfield MA, Anjohrin SB, Lupo PJ, Jackson DR, Stallings EB, Scheuerle AE, Kirby RS; National Birth Defects Prevention Network.

Birth Defects Res A Clin Mol Teratol. 2015 Nov;103(11):972-93. doi: 10.1002/bdra.23461. No abstract available.

38.

Assessment of YouTube videos as a source of information on medication use in pregnancy.

Hansen C, Interrante JD, Ailes EC, Frey MT, Broussard CS, Godoshian VJ, Lewis C, Polen KN, Garcia AP, Gilboa SM.

Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):35-44. doi: 10.1002/pds.3911. Epub 2015 Nov 5.

39.

CDC Grand Rounds: Understanding the Causes of Major Birth Defects - Steps to Prevention.

Simeone RM, Feldkamp ML, Reefhuis J, Mitchell AA, Gilboa SM, Honein MA, Iskander J.

MMWR Morb Mortal Wkly Rep. 2015 Oct 9;64(39):1104-7. doi: 10.15585/mmwr.mm6439a3.

40.

Trends in Gestational Diabetes Among Hospital Deliveries in 19 U.S. States, 2000-2010.

Bardenheier BH, Imperatore G, Gilboa SM, Geiss LS, Saydah SH, Devlin HM, Kim SY, Gregg EW.

Am J Prev Med. 2015 Jul;49(1):12-9. doi: 10.1016/j.amepre.2015.01.026.

41.

The National Birth Defects Prevention Study: A review of the methods.

Reefhuis J, Gilboa SM, Anderka M, Browne ML, Feldkamp ML, Hobbs CA, Jenkins MM, Langlois PH, Newsome KB, Olshan AF, Romitti PA, Shapira SK, Shaw GM, Tinker SC, Honein MA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):656-69. doi: 10.1002/bdra.23384. Epub 2015 Jun 2. Review.

42.

Estimated number of infants detected and missed by critical congenital heart defect screening.

Ailes EC, Gilboa SM, Honein MA, Oster ME.

Pediatrics. 2015 Jun;135(6):1000-8. doi: 10.1542/peds.2014-3662. Epub 2015 May 11.

43.

Methods for surveillance of fetal alcohol syndrome: The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) - Arizona, Colorado, New York, 2009 - 2014.

O'Leary LA, Ortiz L, Montgomery A, Fox DJ, Cunniff C, Ruttenber M, Breen A, Pettygrove S, Klumb D, Druschel C, Frías JL, Robinson LK, Bertrand J, Ferrara K, Kelly M, Gilboa SM, Meaney FJ; FASSNetII.

Birth Defects Res A Clin Mol Teratol. 2015 Mar;103(3):196-202. doi: 10.1002/bdra.23335. Epub 2015 Mar 12.

44.

Racial/ethnic differences in survival of United States children with birth defects: a population-based study.

Wang Y, Liu G, Canfield MA, Mai CT, Gilboa SM, Meyer RE, Anderka M, Copeland GE, Kucik JE, Nembhard WN, Kirby RS; National Birth Defects Prevention Network.

J Pediatr. 2015 Apr;166(4):819-26.e1-2. doi: 10.1016/j.jpeds.2014.12.025. Epub 2015 Jan 29.

45.

Fetal alcohol syndrome among children aged 7-9 years - Arizona, Colorado, and New York, 2010.

Fox DJ, Pettygrove S, Cunniff C, O'Leary LA, Gilboa SM, Bertrand J, Druschel CM, Breen A, Robinson L, Ortiz L, Frías JL, Ruttenber M, Klumb D, Meaney FJ; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jan 30;64(3):54-7.

46.

Opioid prescription claims among women of reproductive age--United States, 2008-2012.

Ailes EC, Dawson AL, Lind JN, Gilboa SM, Frey MT, Broussard CS, Honein MA; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Jan 23;64(2):37-41.

47.

Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States.

Peterson C, Grosse SD, Li R, Sharma AJ, Razzaghi H, Herman WH, Gilboa SM.

Am J Obstet Gynecol. 2015 Jan;212(1):74.e1-9. doi: 10.1016/j.ajog.2014.09.009. Epub 2014 Oct 28.

48.

Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project.

Simeone RM, Devine OJ, Marcinkevage JA, Gilboa SM, Razzaghi H, Bardenheier BH, Sharma AJ, Honein MA.

Am J Prev Med. 2015 Feb;48(2):195-204. doi: 10.1016/j.amepre.2014.09.002. Epub 2014 Oct 14. Review.

49.

Antihistamines and birth defects: a systematic review of the literature.

Gilboa SM, Ailes EC, Rai RP, Anderson JA, Honein MA.

Expert Opin Drug Saf. 2014 Dec;13(12):1667-98. doi: 10.1517/14740338.2014.970164. Epub 2014 Oct 11. Review.

50.

Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.

Tinker SC, Broussard CS, Frey MT, Gilboa SM.

Matern Child Health J. 2015 May;19(5):1097-106. doi: 10.1007/s10995-014-1611-z.

Supplemental Content

Loading ...
Support Center